002004 华邦健康
已收盘 07-09 15:00:00
资讯
新帖
简况
华邦健康:公司以医药和医疗为主业
证券之星 · 07-07 08:54
华邦健康:公司以医药和医疗为主业
华邦健康:百盛药业资产组分为流通业务及自产业务两个资产组
证券之星 · 07-03
华邦健康:百盛药业资产组分为流通业务及自产业务两个资产组
细胞免疫治疗概念盘中跳水,华邦健康平盘
市场透视 · 07-02
细胞免疫治疗概念盘中跳水,华邦健康平盘
A股午间公告:合金投资控股股东筹划控制权变更事项 股票停牌
格隆汇 · 06-24
A股午间公告:合金投资控股股东筹划控制权变更事项 股票停牌
华邦健康(002004.SZ):夫西地酸乳膏、丙酸氟替卡松乳膏获得药品注册证书
智通财经 · 06-24
华邦健康(002004.SZ):夫西地酸乳膏、丙酸氟替卡松乳膏获得药品注册证书
华邦健康:公司根据可交债发行情况结合有关准则进行会计处理具体情况请关注定期报告
证券之星 · 06-20
华邦健康:公司根据可交债发行情况结合有关准则进行会计处理具体情况请关注定期报告
华邦健康:百盛药业从未生产过注射用甲泼尼龙琥珀酸钠
证券之星 · 06-20
华邦健康:百盛药业从未生产过注射用甲泼尼龙琥珀酸钠
华邦健康:公司控股股东及一致行动人质押融资主要用于置换及偿还前期因增持公司股票和认购公司非公开发行的股票而产生的质押借款及债务
证券之星 · 06-13
华邦健康:公司控股股东及一致行动人质押融资主要用于置换及偿还前期因增持公司股票和认购公司非公开发行的股票而产生的质押借款及债务
草甘膦概念盘中跳水,华邦健康跌1.41%
市场透视 · 06-13
草甘膦概念盘中跳水,华邦健康跌1.41%
每周股票复盘:华邦健康(002004)控股股东股份质押展期及质押情况更新
证券之星 · 06-07
每周股票复盘:华邦健康(002004)控股股东股份质押展期及质押情况更新
华邦健康:公司并购百盛药业形成的商誉与并购时百盛药业资产组可辨认净资产的公允价值有关
证券之星 · 06-05
华邦健康:公司并购百盛药业形成的商誉与并购时百盛药业资产组可辨认净资产的公允价值有关
图解华邦健康一季报:第一季度单季净利润同比增18.50%
证券之星 · 04-22
图解华邦健康一季报:第一季度单季净利润同比增18.50%
华邦健康(002004.SZ)发布一季度业绩,归母净利润1.84亿元,同比增长18.50%
智通财经网 · 04-22
华邦健康(002004.SZ)发布一季度业绩,归母净利润1.84亿元,同比增长18.50%
华邦健康(002004.SZ)发布2024年度业绩,由盈转亏2.99亿元
智通财经网 · 04-22
华邦健康(002004.SZ)发布2024年度业绩,由盈转亏2.99亿元
【华邦健康:2024年净亏损2.99亿元】华邦健康公告,2024年营业收入116.65亿元,同比增长0.60%。归属于上市公司股东的净亏损2.99亿元,去年同期净利润3.02亿元。基本每股收益-0.1514元/股。公司董事会审议通过的利润分配预案为不派发现金红利,不送红股,不以资本公积金转增股本。
金融界 · 04-22
【华邦健康:2024年净亏损2.99亿元】华邦健康公告,2024年营业收入116.65亿元,同比增长0.60%。归属于上市公司股东的净亏损2.99亿元,去年同期净利润3.02亿元。基本每股收益-0.1514元/股。公司董事会审议通过的利润分配预案为不派发现金红利,不送红股,不以资本公积金转增股本。
华邦健康:公司认真学习并将贯彻落实证监会发布的相关指引
证券之星 · 02-21
华邦健康:公司认真学习并将贯彻落实证监会发布的相关指引
华邦健康:目前公司生产经营正常,股票价格受多种因素影响
证券之星 · 01-25
华邦健康:目前公司生产经营正常,股票价格受多种因素影响
华邦健康:2024年业绩较上年同期波动较大的主要原因是计提资产减值准备以及农化新材料板块利润下滑
证券之星 · 01-21
华邦健康:2024年业绩较上年同期波动较大的主要原因是计提资产减值准备以及农化新材料板块利润下滑
华邦健康(002004)1月20日主力资金净卖出1700.68万元
证券之星 · 01-21
华邦健康(002004)1月20日主力资金净卖出1700.68万元
加载更多
公司概况
公司名称:
华邦生命健康股份有限公司
所属行业:
化学原料和化学制品制造业
上市日期:
2004-06-25
主营业务:
华邦生命健康股份有限公司的主营业务为医药及农化、新材料产品的研发、生产、销售,医疗服务、旅游投资及运营业务。公司的主要产品乐夫松、必亮、为豆、维夫欣、力克肺疾、明希欣、速瑞、斯瑞、常罗定、瑞婷、开顺、必与、汉非、海格力、乙氧氟草醚、硝磺草酮、嘧菌酯、噻嗪酮、氟苯等。公司凭借强大的自主登记能力取得多个农药登记证,快速打开市场,先发优势突出。在国内市场,公司拥有的农药产品登记证数量位于领先地位。
发行价格:
9.60
{"stockData":{"symbol":"002004","market":"SZ","secType":"STK","nameCN":"华邦健康","latestPrice":4.32,"timestamp":1752044601000,"preClose":4.33,"halted":0,"volume":16437108,"delay":0,"changeRate":-0.0023,"floatShares":1882000000,"shares":1980000000,"eps":-0.1365,"marketStatus":"已收盘","change":-0.01,"latestTime":"07-09 15:00:00","open":4.32,"high":4.34,"low":4.29,"amount":71002300,"amplitude":0.0115,"askPrice":4.32,"askSize":35,"bidPrice":4.31,"bidSize":560,"shortable":0,"etf":0,"ttmEps":-0.1365,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1752111000000},"marketStatusCode":5,"adr":0,"adjPreClose":4.33,"symbolType":"stock","openAndCloseTimeList":[[1752024600000,1752031800000],[1752037200000,1752044400000]],"highLimit":4.76,"lowLimit":3.9,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":1979919191,"isCdr":false,"pbRate":0.9,"roa":"--","roe":"1.95%","epsLYR":-0.1514,"committee":-0.042189,"marketValue":8553000000,"turnoverRate":0.0087,"status":1,"floatMarketCap":8131000000},"requestUrl":"/m/hq/s/002004","defaultTab":"news","newsList":[{"id":"2549847175","title":"华邦健康:公司以医药和医疗为主业","url":"https://stock-news.laohu8.com/highlight/detail?id=2549847175","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2549847175?lang=zh_cn&edition=full","pubTime":"2025-07-07 16:54","pubTimestamp":1751878457,"startTime":"0","endTime":"0","summary":"证券之星消息,华邦健康(002004)07月07日在投资者关系平台上答复投资者关心的问题。投资者提问:贵公司大部分利润来自医药,为什么在兽药板块,请问公司的主业是什么???华邦健康回复:投资者您好,公司以医药和医疗为主业,持续完善集原料药、制剂、功能性护肤品、泛皮肤健康管理、医疗服务为一体的全产业链发展模式。目前公司暂未生产兽药制剂,但控股子公司汉江药业生产少量兽药中间体及原料药。谢谢!以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025070700022016.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["09939","BK1574","159891","BK1515","BK0146","BK0174","BK0188","002004","BK0114","159938","BK0229","BK1161","BK0042"],"gpt_icon":0},{"id":"2548841284","title":"华邦健康:百盛药业资产组分为流通业务及自产业务两个资产组","url":"https://stock-news.laohu8.com/highlight/detail?id=2548841284","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2548841284?lang=zh_cn&edition=full","pubTime":"2025-07-03 08:46","pubTimestamp":1751503572,"startTime":"0","endTime":"0","summary":"证券之星消息,华邦健康07月03日在投资者关系平台上答复投资者关心的问题。同时,近年来,由于受药品集采等行业政策影响,百盛药业资产组经营业绩出现大幅下滑,整体业务规模萎缩,故公司对其商誉计提减值,并对组织架构进行了适当优化。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025070300006363.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0146","BK0114","BK0188","BK0042","BK0229","002004","BK0174"],"gpt_icon":0},{"id":"2548783078","title":"细胞免疫治疗概念盘中跳水,华邦健康平盘","url":"https://stock-news.laohu8.com/highlight/detail?id=2548783078","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2548783078?lang=zh_cn&edition=full","pubTime":"2025-07-02 10:15","pubTimestamp":1751422547,"startTime":"0","endTime":"0","summary":"07月02日,细胞免疫治疗概念盘中跳水,截至10点15分,细胞免疫治疗概念整体指数下跌1.02%,报916.510点。从个股上来看,该概念的成分股中,华邦健康平盘,跌幅居前。从资金上来看,截止发稿,细胞免疫治疗概念主力净流入为-3.42亿,其中华海药业受到资金热捧,主力净流入3376.16万;拉长时间线来看,该板块近20日主力资金净流入-56.98亿。(以上内容为腾讯自选股基于公开消息,由程序或算法智能生成,仅作为用户看盘参考,不作为投资建议或交易依据。股市有风险,请谨慎决策。)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250702101547a7297dbe&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250702101547a7297dbe&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0185","BK0028","002004","BK0201","BK0114","BK0146","BK0239","BK0070","BK0012","BK0188","BK0229","BK0042","BK0174","600521"],"gpt_icon":0},{"id":"2545476244","title":"A股午间公告:合金投资控股股东筹划控制权变更事项 股票停牌","url":"https://stock-news.laohu8.com/highlight/detail?id=2545476244","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2545476244?lang=zh_cn&edition=full","pubTime":"2025-06-24 12:06","pubTimestamp":1750738016,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["BK1191","BK0229","BK0081","BK0183","002004","BK0114","BK0174","BK0028","BK0042","01477","600256","BK0274","BK0102","BK0146","BK0212","BK0233","BK0000","BK0196","000633","BK0029","BK0188","BK0004","BK0119","BK1574","BK0019","BK0012","000825","BK0044"],"gpt_icon":0},{"id":"2545765574","title":"华邦健康(002004.SZ):夫西地酸乳膏、丙酸氟替卡松乳膏获得药品注册证书","url":"https://stock-news.laohu8.com/highlight/detail?id=2545765574","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2545765574?lang=zh_cn&edition=full","pubTime":"2025-06-24 11:46","pubTimestamp":1750736804,"startTime":"0","endTime":"0","summary":"智通财经APP讯,华邦健康(002004.SZ)发布公告,公司全资子公司重庆华邦制药有限公司(以下简称“华邦制药”)于近日收到国家药品监督管理局核准签发的关于夫西地酸乳膏和丙酸氟替卡松乳膏的《药品注册证书》。公司子公司华邦制药收到国家药品监督管理局颁发的关于夫西地酸乳膏、丙酸氟替卡松乳膏的药品注册证书,产品正式获批上市,进一步丰富了公司在皮肤领域的产品管线,进一步完善了阶梯化炎症性皮肤病外用治疗、细菌性皮肤感染的产品矩阵。华邦制药产品目前可覆盖炎症性皮肤病、真菌感染、细菌感染、病毒感染、皮肤过敏、皮肤角化、色素性皮肤异常等多类型皮肤疾病治疗领域。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1308822.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"华邦健康(002004.SZ):夫西地酸乳膏、丙酸氟替卡松乳膏获得药品注册证书","news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0114","BK0174","BK0188","BK0229","BK0146","BK0042","002004"],"gpt_icon":0},{"id":"2544434701","title":"华邦健康:公司根据可交债发行情况结合有关准则进行会计处理具体情况请关注定期报告","url":"https://stock-news.laohu8.com/highlight/detail?id=2544434701","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2544434701?lang=zh_cn&edition=full","pubTime":"2025-06-20 15:21","pubTimestamp":1750404082,"startTime":"0","endTime":"0","summary":"证券之星消息,华邦健康(002004)06月20日在投资者关系平台上答复投资者关心的问题。投资者提问:公司发行可交债是按照实际利率法计提财务费用,还是交易性金融负债?华邦健康回复:投资者您好,公司根据可交债发行情况,结合《企业会计准则第22号-金融工具确认和计量》以及《企业会计准则第37号-金融工具列报》有关规定进行会计处理,具体情况请您关注公司定期报告,谢谢。以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025062000016819.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002004","BK0042","BK0188","BK0146","BK0174","BK0114","BK0229"],"gpt_icon":0},{"id":"2544409143","title":"华邦健康:百盛药业从未生产过注射用甲泼尼龙琥珀酸钠","url":"https://stock-news.laohu8.com/highlight/detail?id=2544409143","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2544409143?lang=zh_cn&edition=full","pubTime":"2025-06-20 15:21","pubTimestamp":1750404080,"startTime":"0","endTime":"0","summary":"近年来,百盛药业受药品集采等行业政策影响,导致经营业绩出现大幅下滑,整体业务规模萎缩,故公司对其商誉计提减值。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025062000016817.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0114","002004","BK0229","BK0174","BK0146","BK0042","BK0188"],"gpt_icon":0},{"id":"2543258682","title":"华邦健康:公司控股股东及一致行动人质押融资主要用于置换及偿还前期因增持公司股票和认购公司非公开发行的股票而产生的质押借款及债务","url":"https://stock-news.laohu8.com/highlight/detail?id=2543258682","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2543258682?lang=zh_cn&edition=full","pubTime":"2025-06-13 20:53","pubTimestamp":1749819221,"startTime":"0","endTime":"0","summary":"投资者提问:汇邦科技、张松山及一致行动人因融资需要,质押了 49.54%的股份,请问融资用来经营一致行动人或家族华邦健康外的生意吗?同时,公司控股股东及一致行动人质押总体风险可控,公司也将严格按照相关规则及时履行信息披露义务。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025061300039298.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0146","BK0114","BK0188","BK0042","BK0229","002004","BK0174"],"gpt_icon":0},{"id":"2543953520","title":"草甘膦概念盘中跳水,华邦健康跌1.41%","url":"https://stock-news.laohu8.com/highlight/detail?id=2543953520","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2543953520?lang=zh_cn&edition=full","pubTime":"2025-06-13 10:23","pubTimestamp":1749781410,"startTime":"0","endTime":"0","summary":"06月13日,草甘膦概念盘中跳水,截至10点23分,草甘膦概念整体指数下跌1.05%,报1704.850点。从个股上来看,该概念的成分股中,华邦健康跌1.41%,江山股份、安道麦A、新安股份跌幅居前。从资金上来看,截止发稿,草甘膦概念主力净流入为-2.02亿,其中和邦生物受到资金热捧,主力净流入1079.91万;拉长时间线来看,该板块近20日主力资金净流入-12.65亿。(以上内容为腾讯自选股基于公开消息,由程序或算法智能生成,仅作为用户看盘参考,不作为投资建议或交易依据。股市有风险,请谨慎决策。)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250613102330951a58d7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250613102330951a58d7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0042","BK0114","BK0146","BK0174","002004","BK0188","BK0028","BK0010","BK0229","600596","600389"],"gpt_icon":0},{"id":"2541897347","title":"每周股票复盘:华邦健康(002004)控股股东股份质押展期及质押情况更新","url":"https://stock-news.laohu8.com/highlight/detail?id=2541897347","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2541897347?lang=zh_cn&edition=full","pubTime":"2025-06-07 10:26","pubTimestamp":1749263170,"startTime":"0","endTime":"0","summary":"截至2025年6月6日收盘,华邦健康报收于4.22元,较上周的4.14元上涨1.93%。本周,华邦健康6月6日盘中最高价报4.24元。截至公告披露日,汇邦科技及其一致行动人合计持股数量为543010887股,持股比例27.43%,累计质押数量268990000股,占合计所持股份比例49.54%,占公司总股本比例13.59%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025060700010021.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0146","BK0188","BK0042","BK0229","002004","BK0174","BK0114"],"gpt_icon":0},{"id":"2541780370","title":"华邦健康:公司并购百盛药业形成的商誉与并购时百盛药业资产组可辨认净资产的公允价值有关","url":"https://stock-news.laohu8.com/highlight/detail?id=2541780370","media":"证券之星","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2541780370?lang=zh_cn&edition=full","pubTime":"2025-06-05 20:54","pubTimestamp":1749128043,"startTime":"0","endTime":"0","summary":"1、公司并购百盛药业形成的商誉与并购时百盛药业资产组可辨认净资产的公允价值有关,与注册资本大小无关;2、您所查询的“2名员工”,仅为百盛药业母公司的员工人数,非资产组全部员工;3、近年来由于受药品集采等行业政策影响,百盛药业经营业绩出现大幅下滑,整体业务规模萎缩,故公司对其商誉计提减值,并对组织架构进行了适当优化。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025060500033651.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0114","002004","BK0146","BK0174","BK0188","BK0229","BK0042"],"gpt_icon":0},{"id":"2529305645","title":"图解华邦健康一季报:第一季度单季净利润同比增18.50%","url":"https://stock-news.laohu8.com/highlight/detail?id=2529305645","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2529305645?lang=zh_cn&edition=full","pubTime":"2025-04-23 01:33","pubTimestamp":1745343200,"startTime":"0","endTime":"0","summary":"证券之星消息,华邦健康2025年一季报显示,公司主营收入28.21亿元,同比下降3.24%;归母净利润1.84亿元,同比上升18.5%;扣非净利润1.7亿元,同比上升14.34%;负债率47.3%,投资收益1270.05万元,财务费用5529.83万元,毛利率37.12%。财报数据概要请见下图:以上内容为证券之星据公开信息整理,由智能算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025042300001429.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002004"],"gpt_icon":0},{"id":"2529353335","title":"华邦健康(002004.SZ)发布一季度业绩,归母净利润1.84亿元,同比增长18.50%","url":"https://stock-news.laohu8.com/highlight/detail?id=2529353335","media":"智通财经网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2529353335?lang=zh_cn&edition=full","pubTime":"2025-04-22 23:09","pubTimestamp":1745334598,"startTime":"0","endTime":"0","summary":"智通财经APP讯,华邦健康(002004.SZ)发布2025年一季度报告,第一季度,公司实现营业收入28.21亿元,同比下降3.24%。归属于上市公司股东的净利润1.84亿元,同比增长18.50%。归属于上市公司股东的扣除非经常性损益的净利润1.7亿元,同比增长14.34%。更多港股重磅资讯,下载智通财经app更多港股及海外理财资讯,请点击www.zhitongcaijing.com(搜索“智通财经”);欲加入智通港股投资群,请加智通客服微信(ztcjkf)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1282718.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["002004"],"gpt_icon":0},{"id":"2529533540","title":"华邦健康(002004.SZ)发布2024年度业绩,由盈转亏2.99亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2529533540","media":"智通财经网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2529533540?lang=zh_cn&edition=full","pubTime":"2025-04-22 23:06","pubTimestamp":1745334382,"startTime":"0","endTime":"0","summary":"智通财经APP讯,华邦健康(002004.SZ)发布2024年年度报告,报告期内,公司实现营业收入116.65亿元,同比增长0.60%。归属于上市公司股东的净亏损2.99亿元。归属于上市公司股东的扣除非经常性损益的净亏损3.38亿元。基本每股亏损0.1514元。更多港股重磅资讯,下载智通财经app更多港股及海外理财资讯,请点击www.zhitongcaijing.com(搜索“智通财经”);欲加入智通港股投资群,请加智通客服微信(ztcjkf)","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1282714.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["002004","BK0146","BK0114","BK0188","BK0229","BK0042","BK0174"],"gpt_icon":0},{"id":"2529581566","title":"【华邦健康:2024年净亏损2.99亿元】华邦健康公告,2024年营业收入116.65亿元,同比增长0.60%。归属于上市公司股东的净亏损2.99亿元,去年同期净利润3.02亿元。基本每股收益-0.1514元/股。公司董事会审议通过的利润分配预案为不派发现金红利,不送红股,不以资本公积金转增股本。","url":"https://stock-news.laohu8.com/highlight/detail?id=2529581566","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2529581566?lang=zh_cn&edition=full","pubTime":"2025-04-22 21:50","pubTimestamp":1745329805,"startTime":"0","endTime":"0","summary":"华邦健康公告,2024年营业收入116.65亿元,同比增长0.60%。归属于上市公司股东的净亏损2.99亿元,去年同期净利润3.02亿元。基本每股收益-0.1514元/股。公司董事会审议通过的利润分配预案为不派发现金红利,不送红股,不以资本公积金转增股本。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/04/22215049769593.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["002004"],"gpt_icon":0},{"id":"2513252938","title":"华邦健康:公司认真学习并将贯彻落实证监会发布的相关指引","url":"https://stock-news.laohu8.com/highlight/detail?id=2513252938","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2513252938?lang=zh_cn&edition=full","pubTime":"2025-02-21 17:30","pubTimestamp":1740130252,"startTime":"0","endTime":"0","summary":"证券之星消息,华邦健康(002004)02月21日在投资者关系平台上答复投资者关心的问题。投资者:2024年11月15日,证监会发布《上市公司监管指引第10号——市值管理》,公司也在不同平台会响应政策。请问目前有成果或措施吗?华邦健康董秘:投资者您好,感谢您的关注。公司认真学习并将贯彻落实证监会发布的相关指引,在提高公司质量的基础上,进一步重视市值管理,依法依规运用各类方式提升公司投资价值,谢谢。以上内容为证券之星据公开信息整理,由智能算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025022100029843.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0174","BK0114","BK0146","BK0188","BK0042","BK0229","002004"],"gpt_icon":0},{"id":"2506825907","title":"华邦健康:目前公司生产经营正常,股票价格受多种因素影响","url":"https://stock-news.laohu8.com/highlight/detail?id=2506825907","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2506825907?lang=zh_cn&edition=full","pubTime":"2025-01-25 15:30","pubTimestamp":1737790231,"startTime":"0","endTime":"0","summary":"证券之星消息,华邦健康01月25日在投资者关系平台上答复投资者关心的问题。投资者:公司市值只有70多亿,收购一个子项目,要造成20多亿商誉减值,是否收购项目中存在利益输送或评估造假?否则计提怎么跌的这么猛?","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025012500013662.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0042","BK0229","002004","BK0114","BK0146","BK0174","BK0188"],"gpt_icon":0},{"id":"2505462122","title":"华邦健康:2024年业绩较上年同期波动较大的主要原因是计提资产减值准备以及农化新材料板块利润下滑","url":"https://stock-news.laohu8.com/highlight/detail?id=2505462122","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2505462122?lang=zh_cn&edition=full","pubTime":"2025-01-21 17:30","pubTimestamp":1737451839,"startTime":"0","endTime":"0","summary":"证券之星消息,华邦健康01月21日在投资者关系平台上答复投资者关心的问题。华邦健康董秘:投资者您好,公司整体经营稳健,2024年业绩较上年同期波动较大的主要原因是计提资产减值准备以及农化新材料板块利润下滑。计提资产减值准备不影响公司的现金流,公司具备实施现金分红的条件。同时,公司一直以来十分注重股东回报,连续多年保持高比例分红,具体年度利润分配预案请您关注公司后续公告,谢谢!","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025012100028091.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0229","002004","159703","BK0188","BK0114","BK0174","BK0042","BK0146"],"gpt_icon":0},{"id":"2505265268","title":"华邦健康(002004)1月20日主力资金净卖出1700.68万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2505265268","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2505265268?lang=zh_cn&edition=full","pubTime":"2025-01-21 09:18","pubTimestamp":1737422294,"startTime":"0","endTime":"0","summary":"证券之星消息,截至2025年1月20日收盘,华邦健康报收于3.92元,下跌10.09%,跌停,换手率4.42%,成交量83.18万手,成交额3.28亿元。近5日资金流向一览见下表:华邦健康融资融券信息显示,融资方面,当日融资买入6038.63万元,融资偿还2079.51万元,融资净买入3959.12万元。华邦健康主营业务:农药、医药、化学原料药、医疗健康、旅游服务业等。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025012100006834.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0229","BK0114","BK0042","BK0146","002004","BK0174","BK0188"],"gpt_icon":0}],"profile":{"ret":0,"serverTime":1752068601711,"stockEarnings":[{"period":"1week","weight":0.0334},{"period":"1month","weight":0.0261},{"period":"3month","weight":0.1131},{"period":"6month","weight":0.0046},{"period":"1year","weight":0.1547},{"period":"ytd","weight":-0.042}],"compareEarnings":[{"period":"1week","weight":0.0115},{"period":"1month","weight":0.0331},{"period":"3month","weight":0.0975},{"period":"6month","weight":0.0891},{"period":"1year","weight":0.1968},{"period":"ytd","weight":0.0435}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"华邦生命健康股份有限公司","boardCode":"AI0026","boardName":"化学原料和化学制品制造业","stockholders":"176098人(较上一季度增加129.30%)","perCapita":"10688股","listingDate":"2004-06-25","address":"重庆市渝北区人和星光大道69号","registeredCapital":"197991万元","survey":" 华邦生命健康股份有限公司的主营业务为医药及农化、新材料产品的研发、生产、销售,医疗服务、旅游投资及运营业务。公司的主要产品乐夫松、必亮、为豆、维夫欣、力克肺疾、明希欣、速瑞、斯瑞、常罗定、瑞婷、开顺、必与、汉非、海格力、乙氧氟草醚、硝磺草酮、嘧菌酯、噻嗪酮、氟苯等。公司凭借强大的自主登记能力取得多个农药登记证,快速打开市场,先发优势突出。在国内市场,公司拥有的农药产品登记证数量位于领先地位。","listedPrice":9.6},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.34.3","shortVersion":"4.34.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"华邦健康(002004)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供华邦健康(002004)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"华邦健康,002004,华邦健康股票,华邦健康股票老虎,华邦健康股票老虎国际,华邦健康行情,华邦健康股票行情,华邦健康股价,华邦健康股市,华邦健康股票价格,华邦健康股票交易,华邦健康股票购买,华邦健康股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"华邦健康(002004)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供华邦健康(002004)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}